The rare occurrence of IDH-mutation, a genetic marker of secondary GBM that is mostly absent in primary GBM and its correlation with better prognosis could indicate that this mutation is a hindrance in the progression from low grade glioma (LGG) to GBM since it changes the epigenetic state of multiple genes involved in important cellular processes. This evidence concerns the gene IDH2 and glioma.